Lower GI 2017

NCT02526953 Russian trial (S Gordeev) Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

SCCA Stage I-IIIB

314 patients

capecitabine 825 mg/m2 bid on treatment days and mitomycin C 12 g/m2 on day 1.

capecitabine 825 mg/m2 bid on treatment days and mitomycin C 12 g/m2 on day 1 paclitaxel 45 mg/m2 on days 3,10,17,24,31

Primary Endpoint 3 year DFS